XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 210,171 $ 276,771
Trade receivables and contract assets, net of allowances for credit losses of $23,877 and $25,722, respectively 754,207 780,375
Inventories 336,200 380,259
Prepaid assets 92,631 87,879
Other current assets 101,514 83,378
Total current assets 1,494,723 1,608,662
Property, plant and equipment, net 1,639,978 1,639,741
Venture capital and strategic equity investments 235,987 243,811
Operating lease right-of-use assets, net 385,133 394,029
Goodwill 3,124,592 3,095,045
Intangible assets, net 778,461 864,051
Deferred tax assets 37,963 40,279
Other assets 307,005 309,383
Total assets 8,003,842 8,195,001
Current liabilities:    
Accounts payable 135,963 168,937
Accrued compensation 211,077 213,290
Deferred revenue 251,968 241,820
Accrued liabilities 208,124 227,825
Other current liabilities 205,089 203,210
Total current liabilities 1,012,221 1,055,082
Long-term debt, net and finance leases 2,326,653 2,647,147
Operating lease right-of-use liabilities 432,836 419,234
Deferred tax liabilities 167,746 191,349
Other long-term liabilities 236,669 223,191
Total liabilities 4,176,125 4,536,003
Commitments and contingencies (Notes 2, 11, 13, and 15)
Redeemable noncontrolling interest 40,590 56,722
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,718 shares issued and 51,134 shares outstanding as of September 28, 2024, and 51,338 shares issued and outstanding as of December 30, 2023 517 513
Additional paid-in capital 1,971,413 1,905,578
Retained earnings 2,122,835 1,887,218
Treasury stock, at cost, 584 and zero shares, as of September 28, 2024 and December 30, 2023, respectively (119,621) 0
Accumulated other comprehensive loss (192,871) (196,427)
Total Charles River Laboratories International, Inc. equity 3,782,273 3,596,882
Nonredeemable noncontrolling interests 4,854 5,394
Total equity 3,787,127 3,602,276
Total liabilities, noncontrolling interests and equity $ 8,003,842 $ 8,195,001